Eli Lilly will spend $4.5 billion to build a new plant in Indiana that combines research and manufacturing in a single location. Lilly on Wednesday said the plant, dubbed the Lilly Medicine Foundry, is the first of its kind and will give the Indianapolis drugmaker the ability to research new ways of producing medicines while also scaling up manufacturing of drug for clinical trials for its growing pipeline.